Fundraising Fox

Invitae

San Francisco, US · Delaware corporation · 8 known investors

invitae.com ↗

Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.

BiotechDigital HealthHealthtechMedical Devicesin /invitae@Invitae

Founders & leadership

SG
Shelly GuyerExecutive Officer
EA
Eric AguiarDirector
SG
Sean GeorgeExecutive Officer, Director
CG
Christine GorjancDirector
GC
Geoffrey CrouseDirector
LB
Lee BendekgeyExecutive Officer
RS
Randal ScottExecutive Officer, Director

Investors · 8

Civilization Ventures Management, LlcTiburon · $1M – $10M
Decheng CapitalMenlo Park
Fifty YearsSan Francisco · $250K – $2M
Manta Ray VenturesLondon
Oberland CapitalNew York · $50M – $300M
Prefix CapitalSan Francisco
Tech WildcattersDallas
Aisling CapitalreportedNew Yorkvia Eric Aguiar · board

Reported raises · per SEC filings

Form D private placements
▶$19.7MraisedApr 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shelly GuyerExecutive Officer
  • Christine GorjancDirector
  • Chitra NayakDirector
  • Eric AguiarDirector
  • Sean GeorgeExecutive Officer, Director
  • Lee BendekgeyExecutive Officer
  • Geoffrey CrouseDirector
Offering amount
$19.7M
Amount sold
$19.7M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$52.4MraisedApr 2020 · 58 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoffrey CrouseDirector
  • Sean GeorgeExecutive Officer, Director
  • Christine GorjancDirector
  • Chitra NayakDirector
  • Eric AguiarDirector
  • Shelly GuyerExecutive Officer
  • Lee BendekgeyExecutive Officer
Offering amount
$52.4M
Amount sold
$52.4M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$73.5MraisedAug 2017 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shelly GuyerExecutive Officer
  • Lee BendekgeyExecutive Officer
  • Randal ScottExecutive Officer, Director
  • Christine GorjancDirector
  • Eric AguiarDirector
  • Geoffrey CrouseDirector
  • Sean GeorgeExecutive Officer, Director
Offering amount
$73.5M
Amount sold
$73.5M
Sales commissions
$4.4M
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.1MraisedAug 2017 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Randal ScottExecutive Officer, Director
  • Lee BendekgeyExecutive Officer
  • Shelly GuyerExecutive Officer
  • Sean GeorgeExecutive Officer, Director
  • Geoffrey CrouseDirector
  • Eric AguiarDirector
  • Christine GorjancDirector
Offering amount
$16.1M
Amount sold
$16.1M
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedJun 2017 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shelly GuyerExecutive Officer
  • Eric AguiarDirector
  • Sean GeorgeExecutive Officer, Director
  • Christine GorjancDirector
  • Geoffrey CrouseDirector
  • Lee BendekgeyExecutive Officer
  • Randal ScottExecutive Officer, Director
Offering amount
$6M
Amount sold
$6M
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Acquisitions · 2

Early investors' stakes continue via these deals
Clear Genetics

Gia is an AI-powered chatbot designed to help patients and doctors with genetic testing workflows, including risk assessment, family history collection, and results delivery. It serves cancer patients and those at increased risk for cancer in the United States.

Singular Bio

Genetic screening platform for early pregnancy, acquired by Invitae.

In the news